BEIJING, April 29,
2022 /PRNewswire/ -- Concord Medical Services
Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM),
a healthcare provider specialized in cancer treatment, research,
education and prevention by establishing proton centers, premium
cancer hospitals, and specialty cancer hospitals and operating an
extensive network of radiotherapy and diagnostic imaging centers in
China, today announced that it
filed its annual report on Form 20-F for the fiscal year ended
December 31, 2021 (the "Annual
Report") with the U.S. Securities and Exchange Commission. An
electronic copy of the Annual Report can be accessed on Concord
Medical's investor relations website at http://ir.ccm.cn and on the
SEC's website at www.sec.gov. Shareholders may receive a hard copy
of the Annual Report free of charge upon request. Requests should
be submitted to http://ir.ccm.cn.
About Concord Medical
Concord Medical Services Holdings Limited (NYSE: CCM) is a
healthcare provider featuring a full cycle of premium oncology
services including cancer diagnosis, treatment, education and
prevention. The Company focuses on providing multidisciplinary
cancer care approach in all areas of oncology services in its
cancer hospitals and equipping its hospitals with technologically
advanced equipment such as the state-of-the-art proton therapy
system. Collaborating with domestic and international leading
intelligence, we are striving to improve the quality and
accessibility of cancer care. Our network of medically advanced
cancer hospitals and clinics and partnered hospitals across
China ensures the commitment to
the highest standard of medical services for patients. Because, be
the patients' most trusted anti-cancer partner is our vision. For
more information, please see http://ir.ccm.cn.
View original
content:https://www.prnewswire.com/news-releases/concord-medical-files-2021-annual-report-on-form-20-f-301536673.html
SOURCE Concord Medical Services Holdings Limited